Åsa Hedin, EVP Corporate Strategy, leaves Elekta
Niklas Savander says: “We have a strong appreciation for Åsa’s loyalty and large contribution to Elekta during her years with the Company. We wish her all the best in her future career endeavors.”
Åsa Hedin comments: “It has been a great joy and honor to be part of Elekta for so many years. I’m grateful for all the colleagues and customers that I have enjoyed working closely with. My faith in the importance of what Elekta does to shape the future of cancer care has never been stronger.”
A successor to Åsa Hedin will be announced in due course.
Åsa Hedin has worked for Elekta between 1994 and 2000 and from 2007, when she rejoined the Company to lead Elekta Neuroscience as a member of the Executive Management team. In May 2014 she was appointed Executive Vice President (EVP) Corporate Strategy, assuming responsibility for Strategy, Marketing and Education & Training.
# # #
For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: firstname.lastname@example.org
Time zone: CET: Central European Time
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.